Jesus Corral Jaime

5PUBLICATIONS
42CO-AUTHORS
Molecular targetsEpidemiology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet

|Oct 17, 2022
Withdrawal of dacomitinib treatment due to absence of toxicities is not justified.

Jesus Corral, Tony S Mok, Yi-Long Wu

|Jul 22, 2021
Correction to: SEOM clinical guidelines for anaemia treatment in cancer patients (2020).

Y Escobar Álvarez, R de Las Peñas Bataller, J Perez Altozano

|Mar 26, 2021
SEOM clinical guidelines for anaemia treatment in cancer patients (2020).

Y Escobar Álvarez, R de Las Peñas Bataller, J Perez Altozano

|Feb 17, 2019
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program.

J Corral, M Majem, D Rodríguez-Abreu

Pageof 1